Indian pharmaceutical companies with substantial exposure to the US witnessed a surge of up to 14 percent on today’s trading session, after US President Donald Trump exempted pharmaceutical products from reciprocal tariffs in the sector. The Nifty Pharma index jumped...
Foreign portfolio inflows into Indian equities have been negative since the beginning of 2025. As of mid-February, Foreign Institutional Investors (FIIs) have net sold Indian equities worth Rs 33,527.55 crores. Between February 1 and February 15, their net sales...
Two major block deals involving housing finance and pharmaceutical firms led to a decline in their stock prices. The housing finance firm saw a 1.51% drop, while the pharmaceutical company’s shares fell by 1.15%. Promoters of both firms are selling significant...
Search Topic or Keyword
Easiest Stock Screener Tool!
Best stock discovery tool with +130 filters, built for fundamental analysis. Profitability, Growth, Valuation, Liquidity, and many more filters. Search Stocks Industry-wise, Export Data For Offline Analysis, Customizable Filters.